220 related articles for article (PubMed ID: 36119069)
1. Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy.
Zhong K; Xu Y; Cheng Y; Wen Y; Cai L; He G; Huang H; Fu S; Zhong X; Zheng Y; Chen T; Huang M; Pan M
Front Immunol; 2022; 13():999763. PubMed ID: 36119069
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
3. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
Li S; Li L; Li B; Wang W
Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
Liu PH; Huo TI; Miksad RA
Semin Liver Dis; 2018 Aug; 38(3):242-251. PubMed ID: 30041276
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement.
Cheng S; Yang J; Shen F; Zhou W; Wang Y; Cong W; Yang GS; Cheng H; Hu H; Gao C; Guo J; Li A; Meng Y; Jiang X; Yang Y; Qian G; Luo M; Hu B; Man X; Zhang B; Su C; Zhou F; Li N; Shi J; Wang M; Zheng Y; Guo W; Sun J; Wang H; Lau WY; Wu MC
Oncotarget; 2016 Jun; 7(26):40816-40829. PubMed ID: 27027235
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
7. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
Wang J; Li X; Wang F; Shi D; Zhang J
J Cancer Res Ther; 2021 Jul; 17(3):619-624. PubMed ID: 34269290
[TBL] [Abstract][Full Text] [Related]
8. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
Zhang L; Sun JH; Hou ZH; Zhong BY; Yang MJ; Zhou GH; Wang WS; Huang P; Zhang S; Li Z; Zhu XL; Yan ZP; Ni CF
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):63-72. PubMed ID: 32965582
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.
Jia L; Kiryu S; Watadani T; Akai H; Yamashita H; Akahane M; Ohtomo K
Acta Med Okayama; 2012; 66(2):131-41. PubMed ID: 22525471
[TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma.
Li Z; Zhao M; Qi X; Tang Y; Cheng S
J Cell Mol Med; 2023 Aug; 27(15):2103-2111. PubMed ID: 37349905
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis.
Wang JC; Xia AL; Xu Y; Lu XJ
J Cell Physiol; 2019 Feb; 234(2):1062-1070. PubMed ID: 30256409
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three-dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus.
Su F; Chen KH; Liang ZG; Wu CH; Li L; Qu S; Chen L; Zhu XD; Zhong JH; Li LQ; Xiang BD
Cancer Med; 2018 Sep; 7(9):4387-4395. PubMed ID: 30062844
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
15. Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma.
Zhang M; Ding Q; Bian C; Su J; Xin Y; Jiang X
Exp Cell Res; 2023 May; 426(1):113563. PubMed ID: 36944406
[TBL] [Abstract][Full Text] [Related]
16. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.
Tao ZW; Cheng BQ; Zhou T; Gao YJ
Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):134-144. PubMed ID: 34955380
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
Tan X; Xie P; Liu J; Wu H; Xie Y
Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
[TBL] [Abstract][Full Text] [Related]
19. Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report.
Hidaka Y; Tomita M; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
World J Surg Oncol; 2022 Jul; 20(1):228. PubMed ID: 35831894
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.
Nagai H; Mukozu T; Ogino YU; Matsui D; Matsui T; Wakui N; Momiyama K; Igarashi Y; Sumino Y; Higai K
Anticancer Res; 2015 Apr; 35(4):2269-77. PubMed ID: 25862889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
